Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$41.15 -0.08 (-0.18%)
As of: Oct 21, 2026 · 3:14 PM EDT

Supernus Pharmaceuticals (SUPN) Preferred Shares (2011 - 2012)

Updated

Supernus Pharmaceuticals (SUPN) recorded Preferred Shares of $49,000 in Q1 2012, unchanged from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Preferred Shares (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn -
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn -
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn -
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn -
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn -
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn -
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn -
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn -
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn -
10 Supernus Pharmaceuticals 2.39 Bn 1.04 Bn 185.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 49,000.00
Dec 31, 2011 49,000.00
API Access

Supernus Pharmaceuticals Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=SUPN&period=max&api_key=YOUR_API_KEY